Spasticity and Its Contribution to Hypertonia in Cerebral Palsy

Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar-On, Lynn, Molenaers, Guy, Aertbeliën, Erwin, Van Campenhout, Anja, Feys, Hilde, Nuttin, Bart, Desloovere, Kaat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306250/
https://www.ncbi.nlm.nih.gov/pubmed/25649546
http://dx.doi.org/10.1155/2015/317047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306250/
https://www.ncbi.nlm.nih.gov/pubmed/25649546
http://dx.doi.org/10.1155/2015/317047

Ejemplares similares